Alimera Sciences Sues ANI Pharmaceuticals for Delays in Merger Close

MT Newswires Live
2024/09/11

Alimera Sciences Sues ANI Pharmaceuticals for Delays in Merger Close

Alimera Sciences (ALIM) said Tuesday it filed a lawsuit in the Delaware Court of Chancery to force ANI Pharmaceuticals (ANIP) to complete their merger.

"Alimera has fulfilled all its requirements to close the merger agreement, yet ANI has failed to adhere to its obligation to close on time," the company added.

ANI said Tuesday it is working in good faith to complete the transaction and plans to promptly resolve any delays resulting from discussions about the closing conditions.

ANI agreed to acquire Alimera in June in a deal valued at around $381 million.

Alimera and ANI shares were down 6.7% and 5.3% in recent trading, respectively.

Price: 5.16, Change: -0.40, Percent Change: -7.12

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10